Financhill
Buy
63

RDY Quote, Financials, Valuation and Earnings

Last price:
$14.40
Seasonality move :
4.78%
Day range:
$14.05 - $14.31
52-week range:
$12.26 - $16.89
Dividend yield:
0.67%
P/E ratio:
21.52x
P/S ratio:
3.06x
P/B ratio:
3.00x
Volume:
1.4M
Avg. volume:
2.4M
1-year change:
1.48%
Market cap:
$11.8B
Revenue:
$3.9B
EPS (TTM):
$0.66

Earnings Data

Next earnings date for RDY
Jul 25
2025
Most recent earnings per share
$0.22
Beat by $0.22
(May 9/2025)
Consensus Estimate
--
(May 9/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RDY Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
07/25/2025 Q2 $1B -- -- -- --
05/09/2025 Q1 $982.9M $982M $0.22 -- --
01/23/2025 Q4 $937.5M $989.4M $0.20 $0.19 $0.01
11/05/2024 Q3 $914.7M $956.9M $0.04 $0.21 -$0.18
07/27/2024 Q2 $868.2M $919.7M $0.20 $0.21 -$0.01
05/07/2024 Q1 $842M $852.9M $0.19 $0.16 $0.03
01/30/2024 Q4 $831M $866.5M $0.20 $0.16 $0.04
10/27/2023 Q3 $816.3M $832.1M $0.04 $0.14 -$0.10
07/26/2023 Q2 $779.2M $820.2M $0.21 $0.13 $0.08
05/10/2023 Q1 $757.4M $766.6M $0.14 $0.13 $0.01
01/25/2023 Q4 -- $824.4M $0.18 -- --
10/28/2022 Q3 -- $790.4M $0.17 -- --
07/28/2022 Q2 -- $676M $0.19 -- --
05/19/2022 Q1 -- $722.9M $0.01 -- --
01/28/2022 Q4 -- $709.7M $0.11 -- --
10/29/2021 Q3 -- $777.8M $0.16 -- --
07/27/2021 Q2 -- $667.1M $0.09 -- --
05/14/2021 Q1 -- $648.4M $0.09 -- --
01/29/2021 Q4 -- $666.5M $0.00 -- --
10/28/2020 Q3 -- $656.9M $0.12 -- --
07/29/2020 Q2 -- $579.8M $0.09 -- --
05/20/2020 Q1 -- $610.3M $0.13 -- --
01/27/2020 Q4 -- $614.8M -$0.10 -- --
11/01/2019 Q3 -- $680.7M $0.19 -- --
07/29/2019 Q2 -- $551.6M $0.11 -- --
03/31/2019 Q1 -- $569.5M $0.07 -- --
12/31/2018 Q4 -- $533.6M $0.08 -- --
09/30/2018 Q3 -- $541.3M $0.09 -- --
06/30/2018 Q2 -- $555M $0.08 -- --
03/31/2018 Q1 -- $549.3M $0.06 -- --
12/31/2017 Q4 -- $588.3M $0.06 -- --
09/30/2017 Q3 -- $551.6M $0.05 -- --
06/30/2017 Q2 -- $514.1M $0.01 -- --
03/31/2017 Q1 -- $530.6M $0.06 -- --
02/04/2017 Q4 -- $549.9M $0.08 -- --
10/25/2016 Q3 -- $535.7M $0.05 -- --
07/26/2016 Q2 -- $483.4M $0.02 -- --
05/12/2016 Q1 -- $556.4M $0.01 -- --
02/09/2016 Q4 -- $601.9M $0.10 -- --
10/29/2015 Q3 -- $614.4M $0.13 -- --
07/30/2015 Q2 -- $592.6M $0.12 -- --

Dr Reddy's Laboratories Earnings Questions

  • How Much did Dr Reddy's Laboratories Generate in Revenue Last Quarter?

    Dr Reddy's Laboratories reported $982M worth of top line sales in its most recent quarter.

  • Did Dr Reddy's Laboratories Beat Earnings Last Quarter?

    Dr Reddy's Laboratories announced earnings per share of $0.22 which represents a beat of analyst forecast a -- per share.

  • Is Dr Reddy's Laboratories Profitable?

    Dr Reddy's Laboratories reported $653M that represents $0.78 per share over the last quarter.

  • What is the Analyst Consensus for Dr Reddy's Laboratories EPS Next Year?

    Dr Reddy's Laboratories's earnings are forecast to grow from $0.80 per share to $0.83 per share next year representing an increase of 0.53%.

  • When is Dr Reddy's Laboratories's Earnings Date?

    Dr Reddy's Laboratories's next earnings date is July 25, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Will Bloom Energy Stock Go?
How High Will Bloom Energy Stock Go?

Bloom Energy (NYSE:BE) has seen its shares surge by more…

Is Acuity a Good Stock to Buy Now?
Is Acuity a Good Stock to Buy Now?

Acuity Brands (NYSE:AYI) is an industrial company specializing in lighting.…

What Stocks Are Recession-Proof?
What Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Stock Ideas

Buy
68
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 38x

Buy
74
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
49
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
71
NUTX alert for May 15

Nutex Health [NUTX] is up 5.11% over the past day.

Buy
81
EXEL alert for May 15

Exelixis [EXEL] is up 6.45% over the past day.

Sell
29
GLBE alert for May 15

Global E Online [GLBE] is down 2.77% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock